title: Artemisinin combination therapies and malaria parasite drug resistance: the game is afoot.
authors.affiliation: Division of Infectious Diseases and International Health, Duke University Medical Center Duke Global Health Institute, Durham, North Carolina Department of Epidemiology, Gillings School of Global Public Health.
authors.forename: Steve M
authors.initials: SM
authors.lastname: Taylor
authors.affiliation: Division of Infectious Diseases, School of Medicine Curriculum in Genetics and Molecular Biology, University of North Carolina, Chapel Hill.
authors.forename: Jonathan J
authors.initials: JJ
authors.lastname: Juliano
mesh_terms: D037621:Artemisinins / Q000627:therapeutic use*; D004351:Drug Resistance / Q000235:genetics*; D005260:Female; D006801:Humans; D016778:Malaria, Falciparum / Q000188:drug therapy*; D008297:Male; D010963:Plasmodium falciparum / Q000187:drug effects* / Q000235:genetics*; D011110:Polymorphism, Genetic
chemical_list: D037621:Artemisinins; C031327:artemisinin
keywords: Plasmodium; artemisinin; drug resistance; malaria